EMA is approving Zynteglo gene therapy for patients with beta-thalassemia
The Committee for Medicinal Products for Human Use (EMA) recommends…
Johnson & Johnson introduces light adaptive contact lenses to the US market
Johnson & Johnson Vision brings light adaptive contact lenses…
The first antidote to Dabigatran was approved in Russia
Boehringer Ingelheim announced the authorization of Idarucizumab…
X7 Research at IPhEB Russia 2019
X7 Research took part in the last IPhEB Russia 2019 exhibition…